Abstract
Eli Lilly and Company v. Government of Canada, Final Award, UNCITRAL, ICSID Case No. UNCT/14/2, 16 March 2017
For the first time in investment arbitration, a tribunal has ruled in a case involving the invalidation of a pharmaceutical company’s patents by Canadian courts in an investment-based claim.